WeVote
Log In

Bill

Bill

A 1809

Relates to the storage of evidence by law enforcement agencies

2025 Regular Session Introduced by Harvey Epstein and 4 co-sponsors

Establish a central newborn sickle cell trait registry with mandatory parental counseling and staged follow-up to inform health, reproduction, and care.

REPORTED REFERRED TO WAYS AND MEANS
0
WeVote Research Nonpartisan
Bill Summary · A 1809

Summary: A 1809 — Central Registry for Sickle Cell Trait and Related Counseling

Note on title: The bill’s formal title listed in the provided material references storage of evidence by law enforcement, but the introduced content clearly centers on newborn screening for sickle cell trait, a central registry, and related genetic counseling. This summary reflects the introduced text’s substantive provisions on sickle cell trait.

Overview

  • Bill Number: A 1809
  • Introduced: January 9, 2024
  • Current status: REPORTED REFERRED TO WAYS AND MEANS (as of January 28, 2025)
  • Primary aim: Create a central registry for newborns diagnosed with sickle cell trait, ensure parental notification about genetic counseling, and establish ongoing follow-up and educational resources for patients and families.

What the bill would do

  • Establish a central registry for patients diagnosed with sickle cell trait as part of newborn screening programs.
  • Require communication to families about genetic counseling and the health, reproductive, and follow-up implications of sickle cell trait.
  • Create structured follow-up notifications at key developmental stages (early adolescence, later adolescence, and additional intervals as designated) to inform families about medical considerations and available services.
  • Ensure confidentiality of registry data, with penalties for improper disclosure.

Key provisions

1) Notification and registry entry (Section 1)
- When newborn screening detects sickle cell trait, the lab must:
- Notify the physician responsible for the newborn’s care.
- Document the trait in the central registry (to be established under the bill).
- The physician must provide parents with information about genetic counseling, performed by a licensed genetic counselor, including:
- That one or both parents may carry sickle cell trait.
- The risk that other children may carry trait or have sickle cell disease.

2) Central registry and follow-up notifications (Section 2)
- The Commissioner of Health must establish:
- A central registry for patients diagnosed with sickle cell trait.
- A system to notify parents that follow-up medical consultations with a physician are recommended, notably:
- Early adolescence (when children may participate in strenuous activities with potential trait-related adverse symptoms).
- Later adolescence (to inform about reproductive implications).
- Additional intervals as required by the Commissioner.
- A system to notify those who reach age 18 about their registry inclusion and available educational services and genetic counseling.

  • Data use and confidentiality:
    • Registry information may be used to compile statistics and support follow-up counseling and education.
    • Information is confidential and not publicly disclosed except as provided by law.
    • Unauthorized disclosures are a disorderly persons offense; each violation constitutes a separate offense.

3) Effective date (Section 3)
- The act would take effect 90 days after enactment.

Affected parties

  • New Jersey newborns diagnosed with sickle cell trait.
  • Parents/guardians of affected newborns.
  • Physicians/screening laboratories performing newborn screenings.
  • The Department of Health and licensed genetic counselors.
  • Educational and counseling services providers supporting patients and families.

Procedural and timeline notes

  • Legislative history:
    • Introduced in the Assembly (A 1809) on January 9, 2024.
    • Committee action: Health Committee referral; later action places include Ways and Means and Codes.
  • Related legislation:
    • Companion/Senate bills: S 2516 and S 5862 (companions).
    • Prior-session A 5343.
  • Effective date pending enactment; 90-day post-enactment commencement.

Potential impact and considerations

  • Public health: Improved awareness, counseling, and long-term management for individuals with sickle cell trait; potential impacts on athletic participation policies and reproductive planning.
  • Privacy: Strong confidentiality protections with penalties for unlawful disclosure.
  • Implementation: Establishment of a central registry and development of forms/processes prescribed by the Commissioner of Health; budget and staffing implications for the Department of Health.
  • Fiscal: Potential costs for registry infrastructure, outreach, and counseling services; offset by long-term health education benefits.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.